Comparison of Survival in Advanced Non-Small Cell Lung Cancer Patients in the Pre- and Post-Gefitinib Eras

Publisher： Karger

E-ISSN： 1423-0232|76|4|239-246

ISSN： 0030-2414

Source： Oncology, Vol.76, Iss.4, 2009-02, pp. : 239-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Gefitinib Readministration in Patients with Advanced Non-Small Cell Lung Cancer and Previous Response to Gefitinib

By  

Oncology, Vol. 79, Iss. 5-6, 2011-04 ,pp. : 423-429

Karger

Access to resources Recommend Favorite

Gefitinib-Induced Hepatotoxicity in Patients Treated for Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 9, 2012-08 ,pp. : 509-513

Karger

Access to resources Recommend Favorite

Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation

By  

Oncology, Vol. 87, Iss. 4, 2014-07 ,pp. : 215-223

Karger

Access to resources Recommend Favorite

Clinical Significance of Pretreatment C-Reactive Protein in Patients with Advanced Nonsquamous, Non-Small Cell Lung Cancer Who Received Gefitinib

By  

Oncology, Vol. 79, Iss. 5-6, 2011-03 ,pp. : 355-362

Karger

Access to resources Recommend Favorite

Survival of Patients with Advanced Non-Small Cell Lung Cancer Enrolled in Clinical Trials

By  

Oncology, Vol. 91, Iss. 4, 2016-07 ,pp. : 185-193

Karger

Access to resources Recommend Favorite